Latest & greatest articles for depression

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on depression or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on depression and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for depression

121. Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder

Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder - Health Quality Ontario (HQO) Let's make our health system healthier Open Menu Quick Links Loading Loading A A A Evidence to Improve Care Share: Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder Ontario Health Technology Advisory Committee Recommendation The Ontario Health Technology Advisory Committee recommends (...) that evidence-based, structured, individual and group psychotherapy provided by nonphysicians be publicly funded for patients with major depressive disorder and/or generalized anxiety disorder Major depressive disorder and generalized anxiety disorder are among the most commonly diagnosed mental illnesses in Canada. People with major depressive disorder experience sadness and loss of interest or pleasure in activities they once found rewarding. People with generalized anxiety disorder experience persistent

Health Quality Ontario2017

122. Improving the Efficiency of Psychotherapy for Depression: Computer-Assisted Versus Standard CBT

Improving the Efficiency of Psychotherapy for Depression: Computer-Assisted Versus Standard CBT 28969439 2017 10 03 1535-7228 2017 Oct 03 The American journal of psychiatry Am J Psychiatry Improving the Efficiency of Psychotherapy for Depression: Computer-Assisted Versus Standard CBT. appiajp201717010089 10.1176/appi.ajp.2017.17010089 The authors evaluated the efficacy and durability of a therapist-supported method for computer-assisted cognitive-behavioral therapy (CCBT) in comparison (...) to standard cognitive-behavioral therapy (CBT). A total of 154 medication-free patients with major depressive disorder seeking treatment at two university clinics were randomly assigned to either 16 weeks of standard CBT (up to 20 sessions of 50 minutes each) or CCBT using the "Good Days Ahead" program. The amount of therapist time in CCBT was planned to be about one-third that in CBT. Outcomes were assessed by independent raters and self-report at baseline, at weeks 8 and 16, and at posttreatment months

EvidenceUpdates2017

123. The Nottingham Fatigue after Stroke (NotFAST) study: factors associated with severity of fatigue in stroke patients without depression

The Nottingham Fatigue after Stroke (NotFAST) study: factors associated with severity of fatigue in stroke patients without depression 28933604 2017 09 21 1477-0873 31 10 2017 Oct Clinical rehabilitation Clin Rehabil The Nottingham Fatigue after Stroke (NotFAST) study: factors associated with severity of fatigue in stroke patients without depression. 1406-1415 10.1177/0269215517695857 To identify factors associated with post-stroke fatigue in a sample of stroke survivors without depression (...) . Cross-sectional cohort study. Recruitment was from four stroke units in the UK. Participants were assessed within four to six weeks of first stroke; those with high levels of depressive symptoms (score ⩾7 Brief Assessment Schedule Depression Cards) were excluded. Participants were assessed after stroke on the Fatigue Severity Scale of the Fatigue Assessment Inventory, the Rivermead Mobility Index, Nottingham Extended Activities of Daily Living scale, Beck Anxiety Index, Sleep Hygiene Index, 6m walk

EvidenceUpdates2017

124. Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial

Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial 28969438 2017 10 03 1535-7228 2017 Oct 03 The American journal of psychiatry Am J Psychiatry Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial. appiajp201716101200 10.1176/appi.ajp.2017.16101200 Patients with bipolar disorder have recurrent major depression, residual mood symptoms, and limited treatment options. Building on promising (...) pilot data, the authors conducted a 6-week randomized double-blind placebo-controlled trial to investigate the efficacy of adjunctive bright light therapy at midday for bipolar depression. The aims were to determine remission rate, depression symptom level, and rate of mood polarity switch, as well as to explore sleep quality. The study enrolled depressed adults with bipolar I or II disorder who were receiving stable dosages of antimanic medication (excluding patients with hypomania or mania, mixed

EvidenceUpdates2017

125. Maternal mental health and child problem behaviours: disentangling the role of depression and borderline personality dysfunction

Maternal mental health and child problem behaviours: disentangling the role of depression and borderline personality dysfunction 300 Maternal mental health and child problem behaviours: disentangling the role of depression and borderline personality dysfunction Fay Huntley, Nicola Wright, Andrew Pickles, Helen Sharp and Jonathan Hill Background It is not known whether associations between child problem behaviours and maternal depression can be accounted for by comorbid borderline personality (...) disorder (BPD) dysfunction. Aim To examine the contributions of maternal depression and BPD symptoms to child problem behaviours. Method Depression trajectories over the first-year postpartum were generated using repeated measurement from a general population sample of 997 mothers recruited in pregnancy. In a stratified subsample of 251, maternal depression and BPD symptoms were examined as predictors of child problem behaviours at 2.5 years. Results Child problem behaviours were predicted by a high

BJPsych open2017 Full Text: Link to full Text with Trip Pro

126. Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study

Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study ORIGINAL RESEARCH ARTICLE Estimating Prevalence and Healthcare Utilization for Treatment- Resistant Depression in Japan: A Retrospective Claims Database Study Jo ¨rg Mahlich 1,2 • Sunny Tsukazawa 1 • Frank Wiegand 3 Published online: 28 November 2017 The Author(s) 2017. This article is an open access publication Abstract Background Majordepressivedisorders(MDDs (...) )including treatment-resistant depression (TRD) are common dis- abling conditions, but data on their epidemiology in Japan are limited. This study investigated the incidence, epi- demiology, and direct medical costs of TRD and pharma- ceutically-treated depression (PTD) in Japan to increase our health economic understanding of this phenotype of MDD. Methods A retrospective cohort study from a private health insurance claims database estimated the 1-year incidence of PTD and TRD and described the health

Drugs - real world outcomes2017 Full Text: Link to full Text with Trip Pro

127. The effects of combined sertraline and aspirin therapy on depression severity among patients with major depressive disorder: A randomized clinical trial

The effects of combined sertraline and aspirin therapy on depression severity among patients with major depressive disorder: A randomized clinical trial Electronic Physician (ISSN: 2008-5842) http://www.ephysician.ir November 2017, Volume: 9, Issue: 11, Pages: 5770-5777, DOI: http://dx.doi.org/10.19082/5770 Corresponding author: Dr. Hosein Fahimi, Department of Psychiatry, School of Medicine, Kashan University of Medical Science, Kashan, Iran. Tel: +98.3155540021; Email: hossein1fahimi (...) -commercial and no modifications or adaptations are made. Page 5770 The effects of combined sertraline and aspirin therapy on depression severity among patients with major depressive disorder: A randomized clinical trial Zahra Sepehrmanesh 1 , Hosein Fahimi 2 , Goudarz Akasheh 3 , Mohamadreza Davoudi 4 , Hamidreza Gilasi 5 , Amir Ghaderi 6 1 M.D, Psychiatrist, Associate Professor, Department of Psychiatry, School of Medicine, Kashan University of Medical Science, Kashan, Iran 2 M.D, Psychiatrist

Electronic physician2017 Full Text: Link to full Text with Trip Pro

128. Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome

Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome Electronic Physician (ISSN: 2008-5842) http://www.ephysician.ir November 2017, Volume: 9, Issue: 11, Pages: 5820-5825, DOI: http://dx.doi.org/10.19082/5820 Corresponding author: Associate Professor Dr. Akram Ghadiri-Anari, Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Tel: +98.3531833434, Fax: +98.3538224100, Email: ghadiriam@yahoo.com Received: April (...) and no modifications or adaptations are made. Page 5820 Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome Behnaz Enjezab 1 , Maryam Eftekhar 2,3 , Akram Ghadiri-Anari 4 1 Ph.D. in Reproductive Health, Associate Professor, Research Center for Nursing and Midwifery Care, Department of Midwifery, Faculty of Nursing & Midwifery, Shahid Sadoughi University of Medical Sciences, Yazd, Iran 2 M.D., Gynecologist, Associate Professor, Research and Clinical Center

Electronic physician2017 Full Text: Link to full Text with Trip Pro

129. Music therapy for depression.

Music therapy for depression. BACKGROUND: Depression is a highly prevalent mood disorder that is characterised by persistent low mood, diminished interest, and loss of pleasure. Music therapy may be helpful in modulating moods and emotions. An update of the 2008 Cochrane review was needed to improve knowledge on effects of music therapy for depression. OBJECTIVES: 1. To assess effects of music therapy for depression in people of any age compared with treatment as usual (TAU) and psychological (...) , pharmacological, and/or other therapies.2. To compare effects of different forms of music therapy for people of any age with a diagnosis of depression. SEARCH METHODS: We searched the following databases: the Cochrane Common Mental Disorders Controlled Trials Register (CCMD-CTR; from inception to 6 May 2016); the Cochrane Central Register of Controlled Trials (CENTRAL; to 17 June 2016); Thomson Reuters/Web of Science (to 21 June 2016); Ebsco/PsycInfo, the Cumulative Index to Nursing and Allied Health

Cochrane2017

130. Correction: Acceptability of the Fitbit in behavioural activation therapy for depression: a qualitative study

Correction: Acceptability of the Fitbit in behavioural activation therapy for depression: a qualitative study 1 Evid Based Mental Health Month 2017 Vol 0 No 0 Miscellaneous Miscellaneous Correction: Acceptability of the Fitbit in behavioural activation therapy for depression: a qualitative study Chum J, Kim MS, Zielinski L, et al. Acceptability of the Fitbit in behavioural activation therapy for depression: a qualitative study. Evid Based Mental Health 2017;20:128–33. 10.1136/ebmental-2017

Evidence-Based Mental Health2017 Full Text: Link to full Text with Trip Pro

131. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.

Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial. Importance: Major depressive disorder (MDD) is prevalent among patients with chronic kidney disease (CKD) and is associated with morbidity and mortality. The efficacy and adverse events of selective serotonin reuptake inhibitors in these patients are unknown. Objective: To determine whether treatment with sertraline improves depressive symptoms (...) run-in, participants were randomized to sertraline (n = 102) for 12 weeks at an initial dose of 50 mg/d (escalated to a maximum dose of 200 mg/d based on tolerability and response) or matching placebo (n = 99). Main Outcomes and Measures: The primary outcome was improvement in depressive symptom severity from baseline to 12 weeks determined by the 16-item Quick Inventory of Depression Symptomatology-Clinician Rated (QIDS-C16) (score range, 0-27; minimal clinically important difference, 2 points

JAMA2017

132. Sustained effectiveness and cost-effectiveness of the Healthy Activity Programme, a brief psychological treatment for depression delivered by lay counsellors in primary care: 12-month follow-up of a randomised controlled trial

Sustained effectiveness and cost-effectiveness of the Healthy Activity Programme, a brief psychological treatment for depression delivered by lay counsellors in primary care: 12-month follow-up of a randomised controlled trial 28898283 2017 09 12 2017 09 21 2017 09 21 1549-1676 14 9 2017 Sep PLoS medicine PLoS Med. Sustained effectiveness and cost-effectiveness of the Healthy Activity Programme, a brief psychological treatment for depression delivered by lay counsellors in primary care: 12 (...) -month follow-up of a randomised controlled trial. e1002385 10.1371/journal.pmed.1002385 The Healthy Activity Programme (HAP), a brief behavioural intervention delivered by lay counsellors, enhanced remission over 3 months among primary care attendees with depression in peri-urban and rural settings in India. We evaluated the sustainability of the effects after treatment termination, the cost-effectiveness of HAP over 12 months, and the effects of the hypothesized mediator of activation on clinical

EvidenceUpdates2017 Full Text: Link to full Text with Trip Pro

133. Gabapentin (Neurontin): risk of severe respiratory depression

Gabapentin (Neurontin): risk of severe respiratory depression Gabapentin (Neurontin): risk of severe respiratory depression - GOV.UK GOV.UK uses cookies to make the site simpler. Search Gabapentin (Neurontin): risk of severe respiratory depression From: Published: 26 October 2017 Therapeutic area: and Gabapentin has been associated with a rare risk of severe respiratory depression even without concomitant opioid medicines. Patients with compromised respiratory function, respiratory (...) or neurological disease, renal impairment, concomitant use of central nervous system (CNS) depressants, and elderly people might be at higher risk of experiencing severe respiratory depression. Dose adjustments might be necessary in these patients. Contents Advice for healthcare professionals: be aware of the risk of CNS depression, including severe respiratory depression, with gabapentin consider whether dose adjustments might be necessary in patients at higher risk of respiratory depression, including

MHRA Drug Safety Update2017

135. Socioeconomic status indicators and common mental disorders: Evidence from a study of prenatal depression in Pakistan

Socioeconomic status indicators and common mental disorders: Evidence from a study of prenatal depression in Pakistan 29349268 2018 11 13 2352-8273 4 2018 Apr SSM - population health SSM Popul Health Socioeconomic status indicators and common mental disorders: Evidence from a study of prenatal depression in Pakistan. 1-9 10.1016/j.ssmph.2017.10.004 There is growing interest in the relationship between socioeconomic status (SES), poverty, and mental health in low and middle-income countries (...) (LMIC). However, it is not clear whether a gradient approach focused on a wider SES distribution or a binary poverty approach is more salient for mental health in LMIC. Yet this distinction has implications for interventions aimed at improving population health. We contribute to the literature by examining how multiple indicators of socioeconomic status, including gradient SES and binary poverty indicators, contribute to prenatal depression symptoms in a LMIC context. Prenatal depression

SSM - population health2017 Full Text: Link to full Text with Trip Pro

136. Desvenlafaxine versus Venlafaxine for the Treatment of Adult Patients with Major Depressive Disorder: A Review of the Comparative Clinical and Cost-Effectiveness

Desvenlafaxine versus Venlafaxine for the Treatment of Adult Patients with Major Depressive Disorder: A Review of the Comparative Clinical and Cost-Effectiveness Desvenlafaxine versus Venlafaxine for the Treatment of Adult Patients with Major Depressive Disorder: A Review of the Comparative Clinical and Cost-Effectiveness | CADTH.ca Find the information you need Desvenlafaxine versus Venlafaxine for the Treatment of Adult Patients with Major Depressive Disorder: A Review of the Comparative (...) Clinical and Cost-Effectiveness Desvenlafaxine versus Venlafaxine for the Treatment of Adult Patients with Major Depressive Disorder: A Review of the Comparative Clinical and Cost-Effectiveness Published on: October 25, 2017 Project Number: RC0921-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the comparative clinical effectiveness of desvenlafaxine versus venlafaxine for the treatment of adult patients with Major Depressive

Canadian Agency for Drugs and Technologies in Health - Rapid Review2017

137. The role of anxiety and depression on acceptance and action, considering emotional schemas in diabetics of Birjand (Iran)

The role of anxiety and depression on acceptance and action, considering emotional schemas in diabetics of Birjand (Iran) 29238497 2018 11 13 2008-5842 9 10 2017 Oct Electronic physician Electron Physician The role of anxiety and depression on acceptance and action, considering emotional schemas in diabetics of Birjand (Iran). 5551-5559 10.19082/5551 Diabetes is one of the most common noncommunicable diseases around the world that accompanies assorted psychiatric disorders including anxiety (...) and depression due to being chronic. The aim of this study was to evaluate the effect of anxiety and depression on acceptance and action, considering emotional schemas of diabetics referring to diabetes clinics of health centers in Birjand, Iran. This study was conducted in 2016 and was a correlational study with a structural equation modeling approach. The statistical population of this study were all men and women with type 2 diabetes in Birjand, with an active health record in health centers

Electronic physician2017 Full Text: Link to full Text with Trip Pro

138. Acceptability of the Fitbit in behavioural activation therapy for depression: a qualitative study

Acceptability of the Fitbit in behavioural activation therapy for depression: a qualitative study 29056608 2018 08 03 2018 11 13 1468-960X 20 4 2017 Nov Evidence-based mental health Evid Based Ment Health Acceptability of the Fitbit in behavioural activation therapy for depression: a qualitative study. 128-133 10.1136/eb-2017-102763 Major depressive disorder is characterised by low mood and poor motivation. Literature suggests that increased physical activity has positive effects on alleviating (...) depression. Fitness-tracking devices may complement behavioural activation (BA) therapy to improve physical activity and mental health in patients with depression. To understand patients' perceived benefit from the Fitbit and explore themes associated with patient experiences. To compare perceived benefit, patient factors, Fitbit usage and Beck's Depression Inventory (BDI) scores. Semistructured interviews were conducted with patients (n=36) who completed a 28-week BA group programme in a mood disorders

Evidence-Based Mental Health2017 Full Text: Link to full Text with Trip Pro

139. Prevalence of anxiety, depression and post-traumatic stress disorder in the Kashmir Valley

Prevalence of anxiety, depression and post-traumatic stress disorder in the Kashmir Valley 29082026 2018 11 13 2059-7908 2 4 2017 BMJ global health BMJ Glob Health Prevalence of anxiety, depression and post-traumatic stress disorder in the Kashmir Valley. e000419 10.1136/bmjgh-2017-000419 Following the partition of India in 1947, the Kashmir Valley has been subject to continual political insecurity and ongoing conflict, the region remains highly militarised. We conducted a representative cross (...) -sectional population-based survey of adults to estimate the prevalence and predictors of anxiety, depression and post-traumatic stress disorder (PTSD) in the 10 districts of the Kashmir Valley. Between October and December 2015, we interviewed 5519 out of 5600 invited participants, ≥18 years of age, randomly sampled using a probability proportional to size cluster sampling design. We estimated the prevalence of a probable psychological disorder using the Hopkins Symptom Checklist (HSCL-25

BMJ global health2017 Full Text: Link to full Text with Trip Pro

140. Depression, quality of life, and medical resource utilization in sickle cell disease

Depression, quality of life, and medical resource utilization in sickle cell disease 29296845 2018 11 13 2473-9529 1 23 2017 Oct 24 Blood advances Blood Adv Depression, quality of life, and medical resource utilization in sickle cell disease. 1983-1992 10.1182/bloodadvances.2017006940 Sickle cell disease (SCD) is a chronic, debilitating disorder. Chronically ill patients are at risk for depression, which can affect health-related quality of life (HRQoL), health care utilization, and cost. We (...) performed an analytic epidemiologic prospective study to determine the prevalence of depression in adult patients with SCD and its association with HRQoL and medical resource utilization. Depression was measured by the Beck Depression Inventory and clinical history in adult SCD outpatients at a comprehensive SCD center. HRQoL was assessed using the SF36 form, and data were collected on medical resource utilization and corresponding cost. Neurocognitive functions were assessed using the CNS Vital Signs

Blood advances2017 Full Text: Link to full Text with Trip Pro